Bacillus Calmette-Guérin (BCG) therapy is a leading treatment option for bladder cancer, offering an effective approach to prevent recurrence and manage high-grade non-muscle invasive bladder cancer (NMIBC). This bladder cancer immunotherapy targets bladder cancer cells while minimizing harm to healthy tissue, making it a key part of a comprehensive bladder cancer treatment plan.

